Washington (July 19, 2018): The US Food and Drug Administration(FDA) is recalling some Chinese medicines commonly used to help control blood pressure for containing a chemical that’s used to induce cancer in lab rats.
Zhejiang Huahai Pharmaceutical Co. of China inadvertently exposed one ingredient, Valsartan, to an organic chemical called N-nitrosodimethylamine (NDMA).That chemical is considered a probable carcinogen.
According to details, this chemical can be toxic for the liver and other organs. There are well-documented reasons to be worried about NDMA, not least of all its use as a poison in a number of crimes.
The recall applies to three companies: Major Pharmaceuticals, Solco Healthcare, and Teva Pharmaceuticals Industries Ltd.
According to an international report, this recall is particularly complicated because use of drugs with Valsartan is so widespread. The FDA’s drug- shortages team is working to find ways to ensure there will still be an adequate supply.
Related News: